Operating Lease, Right-of-Use Asset of OnKure Therapeutics, Inc. from 31 Mar 2022 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
OnKure Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2022 to 30 Sep 2025.
  • OnKure Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $485,000, a 10% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

OnKure Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $485,000 +$45,000 +10% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $581,000 +$88,000 +18% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $676,000 +$130,000 +24% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $770,000 +$292,000 +61% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $440,000 -$566,000 -56% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $493,000 -$593,000 -55% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $546,000 -$642,000 -54% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $478,000 -$814,000 -63% 31 Dec 2023 10-K 10 Mar 2025 2024 FY
Q3 2023 $1,006,000 -$180,000 -15% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $1,086,000 -$197,000 -15% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $1,188,000 -$194,000 -14% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $1,292,000 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $1,186,000 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $1,283,000 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $1,382,000 31 Mar 2022 10-Q 10 May 2022 2022 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.